Novel antisense inhibition of diacylglycerol O-acyltransferase 2 for treatment of non-alcoholic fatty liver disease: a multicentre, double-blind, randomised, placebo-controlled phase 2 trial
Rohit Loomba(University of California, San Diego), Erin Morgan(Ionis Pharmaceuticals (United States)), Lynnetta M. Watts(Ionis Pharmaceuticals (United States)), Shuting Xia(Ionis Pharmaceuticals (United States)), Lisa A. Hannan(Ionis Pharmaceuticals (United States)), Richard S. Geary(Ionis Pharmaceuticals (United States)), Brenda F. Baker(Ionis Pharmaceuticals (United States)), Sanjay Bhanot(Ionis Pharmaceuticals (United States))
Cited by 117
Abstract
Related Papers
No related papers found
Powered by citation graph analysis